Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-10

Clinical Trial Update: Recombinant Human Prolactin for Lactation Induction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating recombinant human prolactin for lactation induction has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Recombinant Human Prolactin (prolactin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Lactation | Phase 2 | Status: COMPLETED | Results posted: 2013-05-10